282 filings
D
CDTX
Cidara Therapeutics Inc
3 May 24
$240.00 mm in equity, sold $240.00 mm, 7 investors
7:59pm
8-K
CDTX
Cidara Therapeutics Inc
3 May 24
Other Events
8:00am
8-K/A
CDTX
Cidara Therapeutics Inc
29 Apr 24
Entry into a Material Definitive Agreement
4:57pm
8-K
CDTX
Cidara Therapeutics Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:09pm
8-K
CDTX
Cidara Therapeutics Inc
24 Apr 24
Entry into a Material Definitive Agreement
4:07pm
S-8
jjarh7pj1ie7g90gfxm
22 Apr 24
Registration of securities for employees
5:42pm
8-K
sjztn63edwdht
22 Apr 24
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
5:18pm
8-K
a5r0kl64 it
16 Apr 24
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
8:02am
8-K
g0veiu7pu 2j
5 Apr 24
Submission of Matters to a Vote of Security Holders
4:01pm
NT 10-K
bio c7sjmd
1 Apr 24
Notice of late annual filing
8:00am
8-K
s0o8v
9 Feb 24
Other Events
8:00am
8-K
gc809 7sy
22 Dec 23
Other Events
7:33am
8-K
r2b1 yhudbzfe4e9arx
17 Nov 23
Other Events
1:22pm
8-K
ths1zvxd idu
16 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
rca1xl6zgg654u3xetew
2 Nov 23
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:08pm
8-K
njjgyz0q7k3jvvcshk
13 Oct 23
Cidara Therapeutics and Mundipharma receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1
10:36am